Single Payer Isn’t The Only Alternative Healthcare System For The U.S.

Why It Matters

The debate shapes how the U.S. will address rising health costs and insurance gaps, influencing legislation, industry strategy, and consumer access to care.

Key Takeaways

• ACA subsidies expired, premiums spiked sharply.
• Single-payer support at 35% per Pew 2025 survey.
• Multi-payer models like Dutch, Swiss offer regulated competition.
• Profit-driven insurers grew after 1973 HMO Act.

Pulse Analysis

The lapse of ACA premium subsidies has reignited a policy flashpoint: how to protect millions from unaffordable coverage while curbing spiraling health‑care spending. Premiums have jumped sharply, prompting both consumer backlash and a surge of legislative proposals. While the single‑payer vision, championed by figures like Senator Bernie Sanders, promises universal coverage and administrative savings, public opinion remains lukewarm, with only about a third of adults endorsing a national health plan. This disconnect forces policymakers to weigh political feasibility against the allure of systemic overhaul.

International experience offers a nuanced alternative. Countries such as the Netherlands, Switzerland, France, and Germany operate multi‑payer systems that blend private insurers with strong government regulation. These models maintain competitive choice but enforce uniform benefit packages, price caps, and centralized price negotiations, achieving lower per‑capita costs without sacrificing consumer flexibility. By adopting similar regulatory frameworks—standardized coverage, price transparency, and profit‑limiting provisions—the U.S. could capture efficiency gains while preserving the market dynamics that many voters favor. The key lies in aligning private payer incentives with public health goals, a balance that single‑payer advocates often overlook.

Historical context underscores why this shift matters. Prior to the 1973 HMO Act, many insurers operated as nonprofits, emphasizing community rating and uniform premiums. The Act spurred for‑profit entry, deregulated market entry, and ultimately fragmented the insurance landscape. Today’s profit‑driven insurers dominate, contributing to premium volatility and administrative overhead. Revisiting the regulatory ethos of the pre‑HMO era—through stricter price controls, mandatory benefit standards, and limiting profit extraction—could lay the groundwork for a smarter, less fragmented multi‑payer system. Such reforms would address cost growth while respecting the public’s desire for choice, positioning the U.S. for a more sustainable health‑care future.